Navigation Links
Intelident Solutions Reaffirms Proposal to Acquire Zila
Date:7/15/2009

TAMPA, Fla., July 15 /PRNewswire/ -- Intelident Solutions, Inc. ("Intelident") today announced that it has reaffirmed its offer to acquire Zila, Inc. (NasdaqCM: ZILA) for $0.42 per Common share and $0.48 per Preferred share. In addition, Intelident announced that it has filed a complaint in the Delaware Court of Chancery accusing Zila's Directors of breach of fiduciary duty. Intelident has also named Tolmar Holding Inc. and related entities ("Tolmar") as defendants in the complaint, accusing Tolmar of aiding and abetting the breach of fiduciary duties by Zila's Directors.

The five-count complaint alleges that:

  1. Zila's Directors have breached their fiduciary duties to Zila's shareholders by entering into an agreement with Tolmar that prevents the Zila Board from accepting Intelident's Superior Proposal
  2. Tolmar aided and abetted the breach of fiduciary duties by Zila's Directors by insisting upon merger transaction documents that prevent Zila's Directors from meaningfully considering Intelident's Superior Proposal
  3. Zila fraudulently induced Intelident into executing a non-disclosure and standstill agreement by misrepresenting that Intelident could negotiate the purchase of Zila's Senior Secured Notes directly from the Noteholders
  4. The non-disclosure and standstill agreement are unenforceable due to the unlawful manner in which Zila's Directors are attempting to enforce it. For instance, Zila issued an inaccurate and incomplete press release on July 10, 2009, and is attempting to use the non-disclosure and standstill agreement to prevent Intelident from setting the record straight regarding its Superior Proposal
  5. Zila breached the Covenant of Good Faith and Fair Dealing by refusing Intelident's request to present its bid directly to Zila's shareholders

Intelident's complaint re
'/>"/>

SOURCE Intelident Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Intelident Solutions Proposes to Acquire Zila for $0.42 per share in Cash
2. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
3. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
4. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
5. SXC Health Solutions to present at the 2007 UBS Global Life Sciences Conference
6. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
7. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
8. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
9. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
10. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
11. SYMX Builds on Top of New Microsoft Technologies to Offer Hospitals Real-Time Business and Patient Safety Solutions Using RFID Data
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Minneapolis Hosts National Conference on Tobacco or Health October 24-26 on Heels of Minnesota's Statewide, Smoke-Free Law 2Health News:Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4Health News:Hundreds to Gather for Rally in Celebration of Right to Breathe Clean Air 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 3Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 4Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4
Other Medicine Technology:Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5